Diabetic Kidney SGLT2 Simulator Phase 3 Multi-Omics

Trial Presets:
Physiological Hemodynamic Controls Live Direct Manipulation
0%
92 mmHg
210 mg/dL
Nephron Microcirculation & Tubuloglomerular Feedback
Afferolar Resistance
1050dynes
Intraglomerular Pressure
58.0mmHg
Single-Nephron eGFR
138mL/min
Macula Densa NaCl
Low(Signal)
Renal Functional MRI Oxygenation (R2*) BOLD Tissue Mapping
Medullary Hypoxia / Hyperfiltration State
High SGLT2 workload consumes oxygen, elevating medullary R2* relaxation rates.
Medullary R2*:
24.2 s⁻¹
Cortical Perfusion:
112%
RNA-seq & Proteomic Biomarker Panel
Marker Target/Pathology Simulated Conc. Expression
HAVCR1 / KIM-1 Tubular Injury / Stretch 380 pg/mL Elevated
TGFB1 Pro-Fibrotic Signaling 28.4 pg/mL Elevated
COL1A1 Extracellular Matrix Synthesis 18.2 ng/mL Elevated
EDN1 Vascular Endothelin-1 Stress 8.5 pg/mL Elevated
Simulation State: SGLT2 inhibition at 0% allows hyperfiltration (P_gc: 58.0 mmHg, eGFR: 138 mL/min). Medullary R2* is elevated at 24.2 s⁻¹ due to metabolic solute overload.
Enjoy this tool? Build your own with Super